HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J A Thompson Selected Research

J A Thompson Research Topics

Disease

10Neoplasms (Cancer)
01/2020 - 01/2000
6Melanoma (Melanoma, Malignant)
07/2011 - 01/2000
3Renal Cell Carcinoma (Grawitz Tumor)
02/2012 - 04/2001
3Neoplasm Metastasis (Metastasis)
12/2002 - 05/2000
3Neointima
11/2001 - 03/2000
3Vascular System Injuries
11/2001 - 05/2000
2Hypoxia (Hypoxemia)
12/2013 - 07/2001
2Fever (Fevers)
07/2011 - 03/2000
2Wounds and Injuries (Trauma)
11/2004 - 10/2001
2Weight Gain
11/2001 - 11/2000
2Ischemia
10/2001 - 03/2001
2Inflammation (Inflammations)
10/2001 - 03/2001
2Adenocarcinoma
05/2001 - 05/2000
2Carcinogenesis
05/2001 - 05/2000
2Pancreatic Neoplasms (Pancreatic Cancer)
05/2000 - 03/2000
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Leber Congenital Amaurosis
01/2018
1Retinal Diseases
01/2018
1Fetal Growth Retardation (Intrauterine Growth Retardation)
12/2013
1Dehydration (Water Stress)
07/2012
1Seizures (Absence Seizure)
11/2011
1Epilepsy (Aura)
11/2011
1Headache (Headaches)
07/2011
1Fatigue
07/2011
1Nausea
07/2011
1Vomiting
07/2011
1Chills
07/2011
1Botulism
06/2005
1Leukemia
01/2002
1Sickle Cell Anemia (Hemoglobin S Disease)
12/2001
1Colic (Abdominal Cramps)
11/2001
1Hypertension (High Blood Pressure)
03/2001
1Vitiligo
12/2000

Drug/Important Bio-Agent (IBA)

4Peroxynitrous Acid (Peroxynitrite)IBA
10/2001 - 05/2000
3Estrogens (Estrogen)FDA Link
11/2001 - 05/2000
3Proteins (Proteins, Gene)FDA Link
05/2001 - 05/2000
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 08/2001
2IntegrinsIBA
07/2011 - 06/2000
2AntigensIBA
12/2002 - 12/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2001 - 10/2001
2Superoxides (Superoxide)IBA
12/2001 - 10/2001
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2001 - 03/2001
2AntibodiesIBA
11/2001 - 11/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2001 - 07/2001
2Fibroblast Growth Factor 1 (FGF-1)IBA
07/2001 - 05/2001
2Reactive Nitrogen SpeciesIBA
05/2001 - 05/2000
23-nitrotyrosineIBA
05/2001 - 05/2000
2Tyrosine (L-Tyrosine)FDA Link
05/2001 - 05/2000
1Immune Checkpoint InhibitorsIBA
01/2020
1CollagenIBA
12/2013
1Phosphorus (Red Phosphorus)IBA
07/2012
1EverolimusFDA Link
02/2012
1Tyrosine Kinase InhibitorsIBA
02/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2012
1ameroidIBA
11/2011
1Levetiracetam (Keppra)FDA LinkGeneric
11/2011
1AmmoniaIBA
11/2011
1Anticonvulsants (Antiepileptic Drugs)IBA
11/2011
1Bile Acids and Salts (Bile Acids)IBA
11/2011
1Dacarbazine (DIC)FDA LinkGeneric
07/2011
1intetumumabIBA
07/2011
1botulism immune globulinIBA
06/2005
1Biocompatible Materials (Biomaterials)IBA
11/2004
1Interleukin-2 (IL2)IBA
12/2002
1Xanthine OxidaseIBA
12/2001
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
12/2001
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2001
1AnthelminticsIBA
11/2001
1Therapeutic UsesIBA
10/2001
1Oxidoreductases (Dehydrogenase)IBA
08/2001
1(3- dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammoniumIBA
08/2001
1RadiopharmaceuticalsIBA
08/2001
1Liposomes (Liposome)IBA
08/2001
1LipidsIBA
08/2001
1IsotopesIBA
08/2001
1Allovectin-7IBA
08/2001
1Messenger RNA (mRNA)IBA
07/2001
1Oxygen (Dioxygen)IBA
07/2001
1Atrial Natriuretic Factor (ANF)IBA
07/2001
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
07/2001
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
07/2001
1Becaplermin (PDGF-BB)FDA Link
07/2001
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2001
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
07/2001
1Interleukin-12 (IL 12)IBA
04/2001
1Interferon-alpha (Interferon Alfa)IBA
04/2001
1NeopterinIBA
04/2001
1CytokinesIBA
04/2001
1Interleukin-10 (Interleukin 10)IBA
04/2001
1Urethane (Ethyl Carbamate)IBA
03/2001
1Butylated Hydroxytoluene (BHT)IBA
03/2001
1quinone methideIBA
03/2001
1SaltsIBA
03/2001
1Neoplasm Antigens (Tumor Antigens)IBA
12/2000
1Peptides (Polypeptides)IBA
12/2000
1Monophenol Monooxygenase (Tyrosinase)IBA
12/2000

Therapy/Procedure

7Therapeutics
01/2020 - 02/2000
3Immunotherapy
01/2020 - 12/2000
1Surgical Portasystemic Shunt (Portosystemic Shunt)
11/2011
1Ligation
11/2001